Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones
MGX-001 in Hemophilia A Advances Towards US and Ex-US Regulatory Interactions in 2025 NHP Proof-of-Concept Anticipated for Secreted Protein Deficiency...
Clinical Trial
Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment
FemaSeed® patent application provides additional coverage for Femasys’ therapeutic option for women seeking infertility solution ATLANTA, Jan. 16, 2025 (GLOBE...
Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)
ADDIS ABABA, Ethiopia and KINSHASA, Democratic Republic of the Congo and WASHINGTON and PARIS, Jan. 16, 2025 (GLOBE NEWSWIRE) --...
Nusano and Atley Solutions in Collaboration to Accelerate Astatine-211 Development
Nusano isotope production to deliver breakthrough, 100X increase in global At-211 supply, and Atley’s radiopharmaceutical manufacturing technology to enable scalable...
Predictive Oncology Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay
Initial plans target European clinical trials while providing standard testing to clinicians for individual patients There are an estimated 250,000...
Ocugen, Inc. Announces First Patient Dosed in Phase 1 Clinical Trial of OCU200—a Novel Integrin-Targeting Biologic for Diabetic Macular Edema
MALVERN, Pa., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused...
Avacta Announces Positive New Data from the AVA6000 Phase 1 trial Demonstrating Clinically Meaningful Tumor Shrinkage in Patients with Salivary Gland Cancers
Meaningful tumor shrinkage observed in five out of 10 patients with partial and minor responses and 90% disease control rate...
Sibannac, Inc. and Celebrity Television Personality William Henry Announce First Podcast Interview for Starwalker Cafe and Plant Medicine Travel Destinations
Scottsdale, Arizona--(Newsfile Corp. - January 16, 2025) - Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the "Company"), announced the...
Servier and Google Cloud Expand Partnership on using Data and AI
Servier to leverage Google Cloud AI across R&D, production, and distribution, accelerating digital transformation to benefit patients.These new advancements in...
Aptevo’s Peter Pavlik, PhD, Chairing Session on “Bi and Multispecific Biologics” at Cambridge Healthcare Institute’s Pep Talk 2025
Also giving an in-session talk titled "Modular Multispecific Biotherapeutics: Rapid Therapeutic Design with the ADAPTIR® Platform," showcasing Aptevo's drug engineering...
Metagenomi Announces New Appointment to its Board of Directors
EMERYVILLE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing...
Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions
-New FDA Consultant is the former Director of the Division of Imaging, Diagnostics, and Software Reliability at the U.S Food...
Medexus and British Columbia’s Provincial Health Services Authority (PHSA) Successfully Complete Agreement for Public Reimbursement of Trecondyv (treosulfan for injection) in British Columbia, Canada
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - January 15, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) recently completed a...
KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the...
Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the...
BAIBYS™ Announces a Breakthrough in Fertility Treatment with a Newly CE Marked IVF System
The Autonomous Sperm Selection AI-based Robotic System is Poised to Transform the IVF Market TEL AVIV, Israel, Jan. 14, 2025...
BAIBYS™ Announces a Breakthrough in Fertility Treatment with a Newly CE Marked IVF System
The Autonomous Sperm Selection AI-based Robotic System is Poised to Transform the IVF Market TEL AVIV, Israel, Jan. 14, 2025...
BioCentriq Partners with Orchestra Life Sciences to Advance Princeton, NJ Cell Therapy Facility Development
Strategic Partnership to Support Facility Design and Digital Infrastructure ImplementationAccelerates Development of State-of-the-Art Advanced Therapy Manufacturing TechnologiesEnhances Operational Excellence for Clinical-to-Commercial Manufacturing CapabilitiesPRINCETON, N.J., Jan. 14, 2025 /PRNewswire/ -- BioCentriq, a leading cell therapy contract development and manufacturing organization...
BioCentriq Partners with Orchestra Life Sciences to Advance Princeton, NJ Cell Therapy Facility Development
Strategic Partnership to Support Facility Design and Digital Infrastructure ImplementationAccelerates Development of State-of-the-Art Advanced Therapy Manufacturing TechnologiesEnhances Operational Excellence for Clinical-to-Commercial Manufacturing CapabilitiesPRINCETON, N.J., Jan. 14, 2025 /PRNewswire/ -- BioCentriq, a leading cell therapy contract development and manufacturing organization...
ObvioHealth Introduces ObvioGo 2.2: Transforming Study Management with AI-Driven Innovation
AI-Driven Enhancements in ObvioGo 2.2 Redefine Efficiency, Compliance, and Innovation in Clinical Trial Management NEW YORK, Jan. 14, 2025 /PRNewswire/...